Important note: Information in this article was accurate in 2007. The state of the art may have changed since the publication date.
|
|
Reuters (07.06.07) - Wednesday, July 11, 2007
Dr. Gregory D. Kirk of the Bloomberg School of Public Health at Johns Hopkins University in Baltimore and colleagues examined lung cancer deaths in a cohort of injection drug users followed since 1998 as part of an AIDS study. Among the 2,086 participants, 27 lung cancer deaths were identified; 14 of the deaths occurred in subjects with HIV.
After adjusting for potentially confounding factors such as age, sex, and smoking status, the researchers found HIV infection was associated with a 3.6-fold increased risk for lung cancer compared to HIV-negative status.
"As HIV-infected persons survive longer, we are continuing to see that non-AIDS outcomes are becoming the primary causes of morbidity and mortality. Our study suggests that the risks for these non-AIDS outcomes may be modulated by HIV infection," said Kirk.
Kirk said his team plans to combine its data with other HIV and at-risk cohort studies to confirm the association between HIV and lung cancer. "Also, we are evaluating a series of smoking/tobacco related biomarkers in HIV-infected and uninfected persons with similar smoking patterns to compare if the biological effect of smoking differs by HIV status, and if so, is this related to degree of immune suppression or to antiretroviral treatment," he noted.
The study, "HIV Infection Is Associated with an Increased Risk for Lung Cancer, Independent of Smoking," was published in Clinical Infectious Diseases (2007;45(1):103-110).
070711
AD071430
Copyright © 2007 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.
.